Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

OBJECTIVE: To determine the efficacy and safety of deutetrabenazine as a treatment for tardive dyskinesia (TD). METHODS: One hundred seventeen patients with moderate to severe TD received deutetrabenazine or placebo in this randomized, double-blind, multicenter trial. Eligibility criteria included a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurology
Asıl Yazarlar: Fernandez, Hubert H., Factor, Stewart A., Hauser, Robert A., Jimenez-Shahed, Joohi, Ondo, William G., Jarskog, L. Fredrik, Meltzer, Herbert Y., Woods, Scott W., Bega, Danny, LeDoux, Mark S., Shprecher, David R., Davis, Charles, Davis, Mat D., Stamler, David, Anderson, Karen E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5440239/
https://ncbi.nlm.nih.gov/pubmed/28446646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003960
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller